Literature DB >> 19032720

Money makes the world go round: the pervasiveness of pharmacoeconomics.

J M Ritter.   

Abstract

Mesh：

Year:  2008        PMID： 19032720      PMCID： PMC2675758          DOI： 10.1111/j.1365-2125.2008.03335.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  20 in total

1.  Introduction to tripartite meeting report (convenors: Dr Nigel Baber and Prof. Ros Smyth): towards establishing optimal doses for drugs prescribed to children.

Authors:  N S Baber; R Smyth
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

Review 2.  How many genomics targets can a portfolio afford?

Authors:  Ulrich A K Betz
Journal:  Drug Discov Today       Date:  2005-08-01       Impact factor: 7.851

Review 3.  Pharmaceutical company funding and its consequences: a qualitative systematic review.

Authors:  Sergio Sismondo
Journal:  Contemp Clin Trials       Date:  2007-08-16       Impact factor: 2.226

4.  The impact of prognosis without treatment on doctors' and patients' resource allocation decisions and its relevance to new drug recommendation processes.

Authors:  D Ross Camidge; James J Oliver; Carolyn Skinner; Ben Attwood; Fiona Nussey; Duncan Jodrell; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2008-02       Impact factor: 4.335

5.  Sensitivity: real (interferons, odorants) and imagined (homeopathy).

Authors:  J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2008-02       Impact factor: 4.335

6.  Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study.

Authors:  Stefanie Hennig; Ross Norris; Carl M J Kirkpatrick
Journal:  Br J Clin Pharmacol       Date:  2007-11-08       Impact factor: 4.335

7.  Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure.

Authors:  Stefanie Albers; Bernd Meibohm; Thomas S Mir; Stephanie Läer
Journal:  Br J Clin Pharmacol       Date:  2007-11-08       Impact factor: 4.335

8.  Population pharmacokinetic and pharmacogenetic analysis of 6-mercaptopurine in paediatric patients with acute lymphoblastic leukaemia.

Authors:  Ahmed F Hawwa; Paul S Collier; Jeff S Millership; Anthony McCarthy; Sid Dempsey; Carole Cairns; James C McElnay
Journal:  Br J Clin Pharmacol       Date:  2008-09-23       Impact factor: 4.335

9.  Time course of the increase in 4beta-hydroxycholesterol concentration during carbamazepine treatment of paediatric patients with epilepsy.

Authors:  Katarina Wide; Hanna Larsson; Leif Bertilsson; Ulf Diczfalusy
Journal:  Br J Clin Pharmacol       Date:  2008-02-12       Impact factor: 4.335

10.  Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others.

Authors:  Lisa Bero; Fieke Oostvogel; Peter Bacchetti; Kirby Lee
Journal:  PLoS Med       Date:  2007-06       Impact factor: 11.069
View more
  1 in total

1.  From NCE to NICE: the role of pharmacoeconomics.

Authors:  Dyfrig A Hughes
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.